Disclosed are methods and compositions for screening candidate substances for the prevention or treatment of neurodegenerative disorders such as Alzheimer's disease. The disclosure also relates to identifying the mechanisms of action for known or suspected Alzheimer's disease drugs and generally to compositions and methods for modulating the function of cells expressing CD33.
